ISRCTN14189908已完成不适用
Can the DiaGO (Diagnosis of Graves’ orbitopathy) clinical assessment tool reliably and sensitively detect people with and without Graves’ orbitopathy? A multicentre study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of GD
- •2. Hyperthyroidism/subclinical hyperthyroidism and smooth, symmetrical goitre or positive TSH receptor antibodies
- •3. Euthyroid/hypothyroid/hyperthyroid and positive TSH receptor antibodies
排除标准
- •1. People with Graves' Disease already reviewed by ophthalmology
- •2. Remain under the care of ophthalmology with GO
- •3. Children under 18 years of age
研究者
相似试验
进行中（未招募）
不适用
Treatment of Graves’ Orbitopathy (GO) with ATG-Fresenius: A prospective, randomized, open, controlled phase II study to assess the efficacy and safety of an add-on ATG-Fresenius treatment versus a standard steroid treatmentEUCTR2007-005261-35-DEFresenius Biotech GmbH
尚未招募
2 期
Sirolimus for Graves' Orbitopathy (GO)Graves OphthalmopathyNCT04598815University of Pisa54
已完成
不适用
Sirolimus in Graves' OrbitopathyGraves OphthalmopathyNCT05345119University of Pisa30
尚未招募
3 期
A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 StudyGraves' OrbitopathyNCT05049603University of Pisa102
已完成
2 期
Effects of Atorvastatin in Graves' Orbitopathy (GO)Thyroid Associated OphthalmopathyHypercholesterolemiaNCT03110848University of Pisa88